All Pharma News
ABVC BioPharma Executes Licensing Deal for NSCLC Treatment

ABVC BioPharma Executes Licensing Deal for NSCLC Treatment
GLOBENEWSWIRE
17 Apr 2024
Share Share
Skye Bioscience uplists; OncoX`s licensing deal with ABVC BioPharma

Skye Bioscience uplists; OncoX`s licensing deal with ABVC BioPharma
ENDPTS
10 Apr 2024
Share Share
ABVC Bio Executes Global Licensing Term Sheet for Oncology/Hematology Products

ABVC Bio Executes Global Licensing Term Sheet for Oncology/Hematology Products
GLOBENEWSWIRE
10 Apr 2024
Share Share
ABVC Entered into a Global Licensing of Vitargus with Licensing Income of $33.5M

ABVC Entered into a Global Licensing of Vitargus with Licensing Income of $33.5M
GLOBENEWSWIRE
26 Mar 2024
Share Share
AiBtl BioPharma Completes $7.6M Land Deal: Exchanging Stock for Real Estate

AiBtl BioPharma Completes $7.6M Land Deal: Exchanging Stock for Real Estate
GLOBENEWSWIRE
21 Mar 2024
Share Share
ABVC BioPharma CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine

ABVC BioPharma CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine
GLOBENEWSWIRE
19 Mar 2024
Share Share
ABVC BioPharma Reports Annual 2023 Financials

ABVC BioPharma Reports Annual 2023 Financials
GLOBENEWSWIRE
14 Mar 2024
Share Share
ABVC`s New Horizon for Oncology and Hematology Aims at Hundred Billion Dollars

ABVC`s New Horizon for Oncology and Hematology Aims at Hundred Billion Dollars
GLOBENEWSWIRE
27 Feb 2024
Share Share
ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M

ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M
GLOBENEWSWIRE
15 Feb 2024
Share Share
ABVC BioPharma Receives Australian Patent, Valid Until 2040, for MDD

ABVC BioPharma Receives Australian Patent, Valid Until 2040, for MDD
GLOBENEWSWIRE
12 Feb 2024
Share Share